LIG-ES SPAC (220260) - Total Liabilities

Latest as of September 2025: ₩54.42 Billion KRW ≈ $36.88 Million USD

Based on the latest financial reports, LIG-ES SPAC (220260) has total liabilities worth ₩54.42 Billion KRW (≈ $36.88 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

LIG-ES SPAC - Total Liabilities Trend (2016–2024)

This chart illustrates how LIG-ES SPAC's total liabilities have evolved over time, based on quarterly financial data. See LIG-ES SPAC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

LIG-ES SPAC Competitors by Total Liabilities

The table below lists competitors of LIG-ES SPAC ranked by their total liabilities.

Company	Country	Total Liabilities
Cell Biotech Co. Ltd KQ:049960	Korea	₩7.46 Billion
Phenixfin Corporation NASDAQ:PFX	USA	$151.76 Billion
DENARIUS METALS CORP. F:T7C0	Germany	€72.65 Million
Columbus Acquisition Corp Unit NASDAQ:COLAU	USA	$310.21K
Cloud Air Co.Ltd KQ:036170	Korea	₩27.92 Billion
Srithai Superware Public Company Limited BK:SITHAI	Thailand	฿2.45 Billion
CX Technology Corp TW:2415	Taiwan	NT$6.81 Billion
ULMA Construccion Polska SA WAR:ULM	Poland	zł75.00 Million

Liability Composition Analysis (2016–2024)

This chart breaks down LIG-ES SPAC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LIG-ES SPAC market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.83	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how LIG-ES SPAC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for LIG-ES SPAC (2016–2024)

The table below shows the annual total liabilities of LIG-ES SPAC from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩59.04 Billion ≈ $40.01 Million	+63.26%
2023-12-31	₩36.16 Billion ≈ $24.51 Million	-6.10%
2022-12-31	₩38.51 Billion ≈ $26.10 Million	-4.36%
2021-12-31	₩40.26 Billion ≈ $27.29 Million	+58.34%
2020-12-31	₩25.43 Billion ≈ $17.23 Million	+8.10%
2019-12-31	₩23.52 Billion ≈ $15.94 Million	-19.35%
2018-12-31	₩29.17 Billion ≈ $19.77 Million	+36.30%
2017-12-31	₩21.40 Billion ≈ $14.50 Million	+4549.07%
2016-12-31	₩460.27 Million ≈ $311.92K	--

About LIG-ES SPAC

KQ:220260 Korea Specialty Chemicals

Market Cap

$84.68 Million

₩124.96 Billion KRW

Market Cap Rank

#19921 Global

#1048 in Korea

Share Price

₩4705.00

Change (1 day)

-3.19%

52-Week Range

₩3700.00 - ₩8830.00

All Time High

₩17450.00